BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rafael Lopez J, Kaura V, Hopkins P, Liu X, Uryach A, Adams J, Allen PD. Transient Receptor Potential Cation Channels and Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia. Anesthesiology 2020;133:364-76. [PMID: 32665491 DOI: 10.1097/ALN.0000000000003387] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lamboley CR, Pearce L, Seng C, Meizoso-Huesca A, Singh DP, Frankish BP, Kaura V, Lo HP, Ferguson C, Allen PD, Hopkins PM, Parton RG, Murphy RM, van der Poel C, Barclay CJ, Launikonis BS. Ryanodine receptor leak triggers fiber Ca2+ redistribution to preserve force and elevate basal metabolism in skeletal muscle. Sci Adv 2021;7:eabi7166. [PMID: 34705503 DOI: 10.1126/sciadv.abi7166] [Reference Citation Analysis]
2 Oyama K, Zeeb V, Yamazawa T, Kurebayashi N, Kobirumaki-Shimozawa F, Murayama T, Oyamada H, Noguchi S, Inoue T, Inoue YU, Nishino I, Harada Y, Fukuda N, Ishiwata S, Suzuki M. Heat-hypersensitive mutants of ryanodine receptor type 1 revealed by microscopic heating. Proc Natl Acad Sci U S A 2022;119:e2201286119. [PMID: 35925888 DOI: 10.1073/pnas.2201286119] [Reference Citation Analysis]
3 Uryash A, Mijares A, Lopez CE, Adams JA, Lopez JR. Chronic Elevation of Skeletal Muscle [Ca2+]i Impairs Glucose Uptake. An in Vivo and in Vitro Study. Front Physiol 2022;13:872624. [PMID: 35547584 DOI: 10.3389/fphys.2022.872624] [Reference Citation Analysis]
4 Meizoso-Huesca A, Launikonis BS. The Orai1 inhibitor BTP2 has multiple effects on Ca2+ handling in skeletal muscle. J Gen Physiol 2021;153:e202012747. [PMID: 33316029 DOI: 10.1085/jgp.202012747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Creisméas A, Gazaille C, Bourdon A, Lallemand MA, François V, Allais M, Ledevin M, Larcher T, Toumaniantz G, Lafoux A, Huchet C, Anegon I, Adjali O, Le Guiner C, Fraysse B. TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD. J Transl Med 2021;19:519. [PMID: 34930315 DOI: 10.1186/s12967-021-03191-9] [Reference Citation Analysis]